Vittoria Biotherapeutics, a clinical-stage immunotherapy company specializing in the development of innovative cell therapies ...

PHILADELPHIA, PA — Vittoria Biotherapeutics will present groundbreaking research on its innovative Senza5™ platform at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego, CA, ...

Oct. 28, 2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...

A CD5-based ETP-ALL perspective of non-ETP T-ALL. Eur J Haematol. 2014;92(3):211–8. Of note, CD1a and CD8 are typically negative on ETP-ALL blasts. The Abelson leukemia viral oncogene (ABL1), located ...

As an alternative to the systemic delivery of immune checkpoint inhibitors, here the authors develop an in vivo gene-edit strategy using a conductive hydrogel-based electroporation system to ...

Innovative Approach Maps Gene Activity in the Living Human Brain Nov. 25, 2024 — A groundbreaking method to profile gene activity in the living human brain has been developed. This innovative ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...

MA Farage and KW Miller are employees of Proctor and Gamble. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in ...

One that we work on at Vittoria is the CD5 signalling pathway ... some of these newer game-changing modalities like cell and gene therapy and build into what has been historically a very rigid ...